View Single Post
Old 01-12-2008, 02:46 PM   #19
Christine MH-UK
Senior Member
 
Join Date: Sep 2005
Posts: 414
Hi Michka

The problem is that even though 40% is a massive reduction in the rate of recurrence, there are still going to be some women who don't benefit at all.

I had neoadjuvant FEC and it didn't seem to have worked at all and I had severe problems with it. I figure that the taxotere I had after surgery must have done something because I haven't had a recurrence over four years after diagnosis and my prospects were pretty dire and I found taxotere really easy. I had herceptin, but fifteen months after I finished treatment because of when the trial came out.

I guess the good news is that a newly diagnosed her2 positive patient can be pretty confident that the treatments will be worth it.
Christine MH-UK is offline   Reply With Quote